Patent · US Active

Recombinant RSV vaccines

US9492531B2 · kind B2 · utility

0Cited by

13References

16Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Guy Jean Marie Fernand Pierre Baudoux · Rixensart, BE
Normand Blais · Laval, CA
Sonya L. Cyr · Estaimpuis, BE
Patrick Rheault · Oakville, CA
Jean-Louis Ruelle · Limal, BE

Key dates

Filing date	Jun 24, 2010
Grant date	Nov 15, 2016
Priority date	—
Expiry date	Feb 5, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18534
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.